Literature DB >> 22963823

MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion.

Guo-Ping Tian1, Wu-Jun Chen, Ping-Ping He, Shi-Lin Tang, Guo-Jun Zhao, Yun-Cheng Lv, Xin-Ping Ouyang, Kai Yin, Ping-Ping Wang, Hong Cheng, Yuan Chen, Su-Lan Huang, Yuchang Fu, Da-Wei Zhang, Wei-Dong Yin, Chao-Ke Tang.   

Abstract

LPL (lipoprotein lipase) is a rate-limiting enzyme involved in the hydrolysis of triglycerides. Previous studies have shown that microRNA (miR)-467b regulates hepatic LPL expression and plays a role in the progression of steatosis or abnormal lipid retention in obese mice. Macrophage-derived LPL has been shown to promote atherosclerosis. However, if miR-476b influences macrophage LPL expression and the subsequent effects are unknown. Here, we utilized oxLDL-treatment RAW 264.7 macrophages that were transfected with miR-467b mimics or inhibitors to investigate the potential roles of macrophage miR-476b. We found that miR-467b significantly decreased lipid accumulation and IL-6, IL-1β, TNF-α and MCP-1 secretions. Furthermore, our studies suggested an additional explanation for the regulatory mechanism of miR-467b on its functional target, LPL in RAW 264.7 macrophages. Thus, our findings indicate that miR-467b may regulate lipid accumulation and proinflammatory cytokine secretion in oxLDL-stimulated RAW 264.7 macrophages by targeting the LPL gene.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963823     DOI: 10.1016/j.biochi.2012.08.018

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  14 in total

Review 1.  MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Christian Weber
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

Review 2.  MicroRNAs in the onset and development of cardiovascular disease.

Authors:  Kasey C Vickers; Kerry-Anne Rye; Fatiha Tabet
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

3.  MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.

Authors:  Ping-Ping He; Xin-Ping OuYang; Yuan Li; Yun-Cheng Lv; Zong-Bao Wang; Feng Yao; Wei Xie; Yu-Lin Tan; Liang Li; Min Zhang; Gang Lan; Duo Gong; Hai-Peng Cheng; Hui-Juan Zhong; Dan Liu; Chong Huang; Zhao-Xia Li; Xi-Long Zheng; Wei-Dong Yin; Chao-Ke Tang
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

4.  Host Genetic Background Strongly Affects Pulmonary microRNA Expression before and during Influenza A Virus Infection.

Authors:  Matthias Preusse; Klaus Schughart; Frank Pessler
Journal:  Front Immunol       Date:  2017-03-21       Impact factor: 7.561

5.  Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression.

Authors:  Guo-Jun Zhao; Shi-Lin Tang; Yun-Cheng Lv; Xin-Ping Ouyang; Ping-Ping He; Feng Yao; Wu-Jun Chen; Qian Lu; Yan-Yan Tang; Min Zhang; Yuchang Fu; Da-Wei Zhang; Kai Yin; Chao-Ke Tang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

Review 6.  MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment.

Authors:  Jan Novák; Julie Bienertová-Vašků; Tomáš Kára; Miroslav Novák
Journal:  Mediators Inflamm       Date:  2014-04-24       Impact factor: 4.711

7.  Nicotinate-Curcumin Impedes Foam Cell Formation from THP-1 Cells through Restoring Autophagy Flux.

Authors:  Hong-Feng Gu; Hai-Zhe Li; Ya-Ling Tang; Xiao-Qing Tang; Xi-Long Zheng; Duan-Fang Liao
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

8.  MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.

Authors:  Wei Xie; Liang Li; Min Zhang; Hai-Peng Cheng; Duo Gong; Yun-Cheng Lv; Feng Yao; Ping-Ping He; Xin-Ping Ouyang; Gang Lan; Dan Liu; Zhen-Wang Zhao; Yu-Lin Tan; Xi-Long Zheng; Wei-Dong Yin; Chao-Ke Tang
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

9.  A Novel Korean Red Ginseng Compound Gintonin Inhibited Inflammation by MAPK and NF-κB Pathways and Recovered the Levels of mir-34a and mir-93 in RAW 264.7 Cells.

Authors:  Evelyn Saba; Bo Ra Jeon; Da-Hye Jeong; Kija Lee; Youn-Kyoung Goo; Dongmi Kwak; Suk Kim; Seong-Soo Roh; Sung Dae Kim; Seung-Yeol Nah; Man Hee Rhee
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-12       Impact factor: 2.629

10.  MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice.

Authors:  Qiong Ye; Guo-Ping Tian; Hai-Peng Cheng; Xin Zhang; Xiang Ou; Xiao-Hua Yu; Ru-Qi Tan; Feng-Yun Yang; Duo Gong; Chong Huang; Yan-Jun Pan; Jie Zhang; Ling-Yan Chen; Zhen-Wang Zhao; Wei Xie; Liang Li; Min Zhang; Xiao-Dan Xia; Xi-Long Zheng; Chao-Ke Tang
Journal:  J Atheroscler Thromb       Date:  2017-09-01       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.